Botulinum toxin type A for amyotrophic lateral sclerosis lower limb spasm: two case reports
Abstract Background Patients with amyotrophic lateral sclerosis (ALS) often experience spasticity, which can severely affect their ability to perform basic activities like standing and walking, potentially diminishing their already compromised quality of life. Botulinum toxin type A (BTX-A) is a fir...
Saved in:
| Main Authors: | Qiang Duan, Chao Li, Chunxia Wei, Qian Wang, Bo Wang, Liangwen Sun, Yongjing He, Junxia Qin, Xiaoqun Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04266-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of botulinum toxin type A in the treatment of spasticity of the lower limbs in stroke patients. Clinical case
by: A. P. Kovalenko
Published: (2015-02-01) -
sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden
by: Lin Jiao, et al.
Published: (2024-12-01) -
Botulinum toxin treatment of lower extremity spasticity
by: S. E. Khat’kova, et al.
Published: (2017-11-01) -
Use of Botulinum Toxin in the Treatment of Patients with Upper Limb Spasticity After Stroke – a Systematic Review
by: Małgorzata Gucwa, et al.
Published: (2025-07-01) -
The preparations of Botulinum toxin type A in the treatment of lower limb post-stroke spasticity. Clinical observation
by: V. K. Misikov
Published: (2015-02-01)